Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its fourth quarter and full year 2024 ...

Belite Bio, Inc ("BLTE" or the "Company") (Nasdaq: BLTE), a clinical-stage biopharmaceutical drug development company focused ...

Fore Genomics, a leader in pediatric genetic health screening, announced a strategic partnership with Inocras, a leading innovator in whole genome sequencing (WGS) and AI-powered genetic analysis ...

GAINESVILLE, Fla. - Cyclo Therapeutics, Inc. (NASDAQ:CYTH), a clinical-stage biotechnology firm with a market capitalization of $22.15 million, announced positive data from a sub-study of its pivotal ...

The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene ...

Beacon Therapeutics’ laruparetigene zovaparvovec (laru-zova) for the treatment of X-linked retinitis pigmentosa (XLRP) has been granted Regenerative Medicine Advanced Therapy (RMAT) by the US Food and ...

The National Institutes of Health has awarded a $20.6 million grant over five years to establish one of five Human Virome Characterization Centers, or HVCCs, leveraging UCLA leadership and the ...

Low clouds and fog. Low 52F. Winds light and variable. 52°F Low clouds and fog. Low 52F. Winds light and variable. Foggy. Low 49F. Winds light and variable. 49°F Foggy. Low 49F. Winds light and ...

Sanofi S.A. Part Cert 0.02% €8.03M ...

The results were presented at the 2025 American Society of Clinical Oncology Gastrointestinal Cancers Symposium held in San Francisco late last month. They were also published in the Journal of ...